Theralink Technologies Inc Financials
This page shows Theralink Technologies Inc (THER) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2023 annual data. Scores normalized against common benchmarks. How we calculate these scores
Theralink Technologies Inc has an operating margin of -1479.8%, meaning the company retains $-1480 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -2049.6% the prior year.
Theralink Technologies Inc's revenue grew 6.8% year-over-year to $607K, a solid pace of expansion. This earns a growth score of 45/100.
Theralink Technologies Inc's current ratio of 0.03 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While Theralink Technologies Inc generated -$5.8M in operating cash flow, capex of $163K consumed most of it, leaving -$5.9M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Theralink Technologies Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Theralink Technologies Inc generates $0.19 in operating cash flow (-$5.8M OCF vs -$30.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Theralink Technologies Inc earns $-0.5 in operating income for every $1 of interest expense (-$9.0M vs $16.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Theralink Technologies Inc generated $607K in revenue in fiscal year 2023. This represents an increase of 6.8% from the prior year.
Theralink Technologies Inc's EBITDA was -$8.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 23.3% from the prior year.
Theralink Technologies Inc reported -$30.9M in net income in fiscal year 2023. This represents a decrease of 142.6% from the prior year.
Theralink Technologies Inc earned $-0.01 per diluted share (EPS) in fiscal year 2023.
Cash & Balance Sheet
Theralink Technologies Inc generated -$5.9M in free cash flow in fiscal year 2023, representing cash available after capex. This represents a decrease of 7.6% from the prior year.
Theralink Technologies Inc held $997K in cash against $0 in long-term debt as of fiscal year 2023.
Theralink Technologies Inc had 6.15B shares outstanding in fiscal year 2023. This represents an increase of 0.0% from the prior year.
Margins & Returns
Theralink Technologies Inc's gross margin was 79.2% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 18.8 percentage points from the prior year.
Theralink Technologies Inc's operating margin was -1479.8% in fiscal year 2023, reflecting core business profitability. This is up 569.8 percentage points from the prior year.
Theralink Technologies Inc's net profit margin was -5093.6% in fiscal year 2023, showing the share of revenue converted to profit. This is down 2849.9 percentage points from the prior year.
Capital Allocation
Theralink Technologies Inc invested $163K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents an increase of 24.1% from the prior year.
THER Income Statement
| Metric | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84K-53.2% | $179K-11.4% | $202K+19.2% | $170K+207.1% | $55K-81.9% | $305K+85.9% | $164K+742.1% | $20K |
| Cost of Revenue | $53K+32.7% | $40K-20.3% | $50K+97.0% | $25K+135.0% | $11K-83.3% | $65K-35.0% | $99K+479.1% | $17K |
| Gross Profit | $31K-77.8% | $139K-8.5% | $152K+5.5% | $144K+224.6% | $44K-81.5% | $241K+271.6% | $65K+2690.0% | $2K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $0+100.0% | -$640K-287.0% | $342K-19.0% | $423K | $0+100.0% | -$1.5M-367.1% | $545K+4.2% | $523K |
| Operating Income | -$1.5M+33.8% | -$2.3M-21.5% | -$1.9M+10.5% | -$2.1M+16.7% | -$2.6M+64.8% | -$7.3M-431.9% | -$1.4M+11.8% | -$1.6M |
| Interest Expense | $4.6M-10.8% | $5.1M+0.9% | $5.1M+3.4% | $4.9M+164.9% | $1.8M+406.3% | $365K+11.6% | $327K+22.4% | $267K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$19.0M-298.1% | $9.6M+113.7% | $4.5M+152.5% | -$8.6M+76.5% | -$36.5M-374.4% | -$7.7M-349.7% | -$1.7M+6.9% | -$1.8M |
| EPS (Diluted) | $0.00 | N/A | $0.00 | N/A | $-0.01 | N/A | $0.00 | N/A |
THER Balance Sheet
| Metric | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.8M-37.4% | $2.8M+65.2% | $1.7M-23.2% | $2.2M-30.8% | $3.2M+25.0% | $2.6M+8.5% | $2.4M-14.5% | $2.8M |
| Current Assets | $257K-79.7% | $1.3M+458.6% | $226K-49.1% | $444K-67.8% | $1.4M+113.1% | $647K+42.5% | $454K-48.6% | $884K |
| Cash & Equivalents | $24K-97.6% | $997K+3875.8% | $25K-87.9% | $208K-81.6% | $1.1M+187.4% | $393K+213.7% | $125K-72.0% | $447K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $46K+91.5% | $24K+59.4% | $15K-63.1% | $41K-15.9% | $48K+50.3% | $32K-70.6% | $109K-20.2% | $137K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $58.9M+43.8% | $41.0M-16.8% | $49.2M-9.8% | $54.6M+14.8% | $47.6M+405.9% | $9.4M+25.2% | $7.5M+11.7% | $6.7M |
| Current Liabilities | $57.8M+45.1% | $39.8M-17.2% | $48.1M-10.0% | $53.4M+15.2% | $46.4M+1242.0% | $3.5M+69.6% | $2.0M-7.7% | $2.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | $250K | N/A | N/A | N/A |
| Total Equity | -$57.1M-49.9% | -$38.1M+19.8% | -$47.5M+9.2% | -$52.3M-18.1% | -$44.3M-551.4% | -$6.8M-33.0% | -$5.1M-30.5% | -$3.9M |
| Retained Earnings | -$112.8M-20.3% | -$93.8M+9.3% | -$103.4M+4.2% | -$107.9M-8.6% | -$99.3M-58.1% | -$62.8M-14.1% | -$55.1M-3.3% | -$53.3M |
THER Cash Flow Statement
| Metric | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$963K+36.0% | -$1.5M-99.8% | -$753K+56.8% | -$1.7M+2.0% | -$1.8M-91.2% | -$929K+43.4% | -$1.6M-23.9% | -$1.3M |
| Capital Expenditures | N/A | $155K | $0 | $0-100.0% | $8K-81.6% | $43K-48.0% | $83K | N/A |
| Free Cash Flow | N/A | -$1.7M-120.4% | -$753K+56.8% | -$1.7M+2.4% | -$1.8M-83.5% | -$972K+43.6% | -$1.7M | N/A |
| Investing Cash Flow | N/A | -$155K | $0 | $0+100.0% | -$8K+81.6% | -$43K+48.0% | -$83K | N/A |
| Financing Cash Flow | -$11K-100.4% | $2.6M+361.7% | $570K-30.4% | $819K-67.5% | $2.5M+103.3% | $1.2M-11.5% | $1.4M+3.0% | $1.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
THER Financial Ratios
| Metric | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.9%-40.8pp | 77.7%+2.5pp | 75.3%-9.8pp | 85.0%+4.6pp | 80.4%+1.6pp | 78.8%+39.4pp | 39.4%+27.5pp | 11.9% |
| Operating Margin | -1842.9%-540.0pp | -1302.9%-353.6pp | -949.3%+314.8pp | -1264.1%+3394.2pp | -4658.3%-2259.5pp | -2398.7%-1560.6pp | -838.1%+7163.4pp | -8001.5% |
| Net Margin | -22688.3%-28052.0pp | 5363.6%+3140.8pp | 2222.8%+7268.2pp | -5045.4%+60885.3pp | -65930.6%-63412.8pp | -2517.8%-1477.3pp | -1040.6%+8374.8pp | -9415.4% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -1067.3%-1404.7pp | 337.4%+76.6pp | 260.8%+642.0pp | -381.2%+741.1pp | -1122.3%-826.6pp | -295.7%-224.3pp | -71.4%-5.8pp | -65.5% |
| Current Ratio | 0.00-0.0 | 0.03+0.0 | 0.000.0 | 0.01-0.0 | 0.03-0.2 | 0.19-0.0 | 0.22-0.2 | 0.40 |
| Debt-to-Equity | -1.03+0.0 | -1.07-0.0 | -1.040.0 | -1.04-1.0 | -0.01+1.4 | -1.38+0.1 | -1.47+0.2 | -1.72 |
| FCF Margin | N/A | -925.7%-553.8pp | -371.9%+653.9pp | -1025.8%+2201.2pp | -3226.9%-2908.3pp | -318.6%+731.5pp | -1050.1% | N/A |
Note: Shareholder equity is negative (-$38.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Theralink Technologies Inc's annual revenue?
Theralink Technologies Inc (THER) reported $607K in total revenue for fiscal year 2023. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Theralink Technologies Inc's revenue growing?
Theralink Technologies Inc (THER) revenue grew by 6.8% year-over-year, from $568K to $607K in fiscal year 2023.
Is Theralink Technologies Inc profitable?
No, Theralink Technologies Inc (THER) reported a net income of -$30.9M in fiscal year 2023, with a net profit margin of -5093.6%.
What is Theralink Technologies Inc's EBITDA?
Theralink Technologies Inc (THER) had EBITDA of -$8.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
What is Theralink Technologies Inc's gross margin?
Theralink Technologies Inc (THER) had a gross margin of 79.2% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is Theralink Technologies Inc's operating margin?
Theralink Technologies Inc (THER) had an operating margin of -1479.8% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.
What is Theralink Technologies Inc's net profit margin?
Theralink Technologies Inc (THER) had a net profit margin of -5093.6% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.
What is Theralink Technologies Inc's free cash flow?
Theralink Technologies Inc (THER) generated -$5.9M in free cash flow during fiscal year 2023. This represents a -7.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Theralink Technologies Inc's operating cash flow?
Theralink Technologies Inc (THER) generated -$5.8M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Theralink Technologies Inc's total assets?
Theralink Technologies Inc (THER) had $2.8M in total assets as of fiscal year 2023, including both current and long-term assets.
What are Theralink Technologies Inc's capital expenditures?
Theralink Technologies Inc (THER) invested $163K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.
What is Theralink Technologies Inc's current ratio?
Theralink Technologies Inc (THER) had a current ratio of 0.03 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Theralink Technologies Inc's debt-to-equity ratio?
Theralink Technologies Inc (THER) had a debt-to-equity ratio of -1.07 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Theralink Technologies Inc's return on assets (ROA)?
Theralink Technologies Inc (THER) had a return on assets of -1084.5% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
What is Theralink Technologies Inc's cash runway?
Based on fiscal year 2023 data, Theralink Technologies Inc (THER) had $997K in cash against an annual operating cash burn of $5.8M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Theralink Technologies Inc's debt-to-equity ratio negative or unusual?
Theralink Technologies Inc (THER) has negative shareholder equity of -$38.1M as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Theralink Technologies Inc's Piotroski F-Score?
Theralink Technologies Inc (THER) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Theralink Technologies Inc's earnings high quality?
Theralink Technologies Inc (THER) has an earnings quality ratio of 0.19x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Theralink Technologies Inc cover its interest payments?
Theralink Technologies Inc (THER) has an interest coverage ratio of -0.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Theralink Technologies Inc?
Theralink Technologies Inc (THER) scores 11 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.